Biodesix | First Tranche of $10M Series B

Posted in CO Private: Biodesix, Series B

Biodesix (Broomfiled, CO) a commercial-stage molecular diagnostics company focused on proteomic-based diagnostics, closed the first tranche of a $10M Series B financing. The company is enabling personalized health care via their mass spectrometry-based molecular profiling proprietary platform technology, ProTS®, to discover and validate diagnostic tests for the improvement of patient outcomes. Biodesix’ first product, VeriStrat®, [...]

4512009-10-06+13%3A41%3A00admin

Sep

2009

Tape-Delay from the RMLSIC | Part I

Posted in AZ Private: Applied Microarrays, AZ Private: HTG, CO Private: Beacon Biotech, CO Private: Biodesix, NM Private: nanoMR, TX Private: Castle Bio, UT Private: Axial Biotech, UT Private: LineaGen

I had the best intentions of bringing up to the minute information flowing through CLSDF from the content rich Rocky Mountain Life Science Investor Conference however, during the first company presentation slot it quickly became apparent that due to the richness of the subject matter in order to keep up I had to turn off [...]